Cyclandelate

In the US, Cyclandelate (cyclandelate systemic) is a member of the drug class peripheral vasodilators and is used to treat Nocturnal Leg Cramps, Raynaud's Syndrome and Renal Artery Atherosclerosis.

US matches:

• Cyclandelate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C04AX01

CAS registry number (Chemical Abstracts Service)

0000456-59-7

Chemical Formula

C17-H24-O3

Molecular Weight

276

Therapeutic Category

Vasodilator, peripheric

Chemical Name

Benzeneacetic acid, α-hydroxy-, 3,3,5-trimethylcyclohexyl ester

Foreign Names

• Cyclandelatum (Latin)
• Cyclandelat (German)
• Cyclandélate (French)
• Ciclandelato (Spanish)

Generic Names

• Ciclandelato (OS: DCIT)
• Cyclandelate (OS: BAN, JAN)
• Cyclandélate (OS: DCF)
• BS 572 (IS)
• Cyclandelate (PH: USP 32, JP VIII)

Brand Names

• Cyclandelat Streuli
  Streuli Pharma, Switzerland



• Cyclospasmol
  Yamanouchi, Luxembourg



• Vesselon
  New Chem & Pharm, Taiwan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.